Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-06

Clinical Trial Update: Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness [NA]

View source ↗

Summary

A clinical trial evaluating topiramate for dizziness in migraine-associated dizziness was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Migraine, Headache | NA | Status: WITHDRAWN